期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肠道微生态在炎症性肠病诊断与治疗中的应用 被引量：3

原文传递
导出
摘要 IBD包括UC和CD，是一类肠道非特异性慢性炎性疾病，其病因与发病机制未完全明了。
作者 陈立平 王伟 夏冰
机构地区 武汉大学中南医院消化内科湖北省肠病医学临床研究中心肠病湖北省重点实验室
出处 《中华消化杂志》 CAS CSCD 北大核心 2013年第12期808-810,共3页 Chinese Journal of Digestion
基金 国家自然科学基金（81270467） 湖北省科技厅重点项目（2013）
关键词 肠道微生态 炎症性肠病 应用 治疗 诊断 炎性疾病 非特异性 发病机制
分类号 R574 [医药卫生—消化系统]
  • 相关文献

参考文献12

  • 1Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology, 2011, 140: 1720-1728.
  • 2Zhou F, Xia B, Wang F, et al. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti Saccharomyees cerevisiae antibodies in patients with inflammatory bowel disease in China's Mainland. Clin Chim Aeta, 2010, 411:1461-1465.
  • 3Frank DN, St Amand AL, Feldman RA, et al. Molecular- phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Aead Sci U S A, 2007, 104:13780-13785.
  • 4Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology, 2010, 139:1844-1854.
  • 5Papa E, Docktor M, Smillie C, et al. Non invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One, 2012,7: e39242.
  • 6Ciorba MA. A gastroenterologist's guide to probiotics. Clin Gastroenterol Hepatol, 2012,10: 960-968.
  • 7陈瑞红,李远发,杨新,夏冰.微生态制剂对溃疡性结肠炎疗效的系统评价[J].胃肠病学,2012,17(4):221-225. 被引量：29
  • 8Tursi A, Brandimarte G, Papa A, et al. Treatment of relapsing mild to-moderate ulcerative colitis with the probiotic VSL # 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol, 2010, 105:2218-2227.
  • 9Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A, 2008, 105: 16731-16736.
  • 10Ohkusa T, Kato K, Terao S, et al. Newly developed antibiotic combination therapy for ulcerative colitis: double-blind placebo-controlled multicenter trial. Am J Gastroenterol, 2010, 105:1820-1829.

二级参考文献22

  • 1Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences[J]. Gastroenterology, 2004, 126 (6): 1504-1517.
  • 2Gob K, Xiao SD. Inflammatory bowel disease: a survey of the epidemiology in Asia[J]. J Dig Dis, 2009, 10 (1): 1-6.
  • 3Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults [J]. Gut, 2011, 60 (5): 571-607.
  • 4Herias MV, Koninkx JF, Vos JG, et al. Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice[J]. Int J Food Microbiol, 2005, 103 (2): 143-155.
  • 5Bibiloni R, Fedorak RN, Tannock GW, et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis[J]. Am J Gastroenterol, 2005, 100 (7): 1539-1546.
  • 6Huynh HQ, deBruyn J, Guan L, et al. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study[J]. Inflamm Bowel Dis, 2009, 15 (5): 760-768.
  • 7Adam B, Liebregts T, Holtmann G. Maintaining remission of ulcerative colitis with the probiotic Escherichia Coli Nissle 1917 is as effective as with standard mesalazine (Article in German) [J]. Z Gastroenterol, 2006, 44 (3): 267 -269.
  • 8StrausSE等主编.EVIDENCE-BASED MEDICINE: How to Practice and Teach EBM[M].詹思延主译.循证医学实践和教学.北京:北京大学医学出版社.2006:127.
  • 9Ishikawa H, Akedo I, Umesaki Y, et al. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis[J]. J Am Coil Nutr, 2003, 22 (1): 56-63.
  • 10Kato K, Mizuno S, Umesaki Y, et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis [J]. Aliment Pharmacol Ther, 2004, 20 (10): 1133-1141.

共引文献28

同被引文献37

  • 1中华医学会消化病学分会炎症性肠病协作组,欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见(2007年，济南)[J].中华消化杂志,2007,27(8):545-550. 被引量：1018
  • 2GB14925-2001.实验动物环境及设施[S].2001.
  • 3CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66 (2) : 115 -132.
  • 4ARAN V, VICTORINO A P, THULER L C, et al. Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality [ J]. Clin Colorectal Cancer, 2016.
  • 5KYRO C, SKEIE G, LOFT S, et al. Adherence to a healthy Nordic food index is associated with a lower incidence of colorectal cancer in women: the Diet, Cancer and Health cohort study [ J ]. Br J Nutr, 2013, 109 (5): 920-927.
  • 6LIU Z, BROOKS R S, CIAPPIO E D, et al. Diet - induced obesity elevates colonic TNF - alpha in mice and is accompanied by an activation of Wnt signaling: a mechanism for obesity - associated colorectal cancer [ Jl. J Nutr Biochem, 2012, 23 (10) : 1207 -1213.
  • 7O'KEEFE S J, LI J V, LAHTI L, et al. Fat, fibre and cancer risk in African Americans and rural Africans [J]. Nat Commun, 2015, 6 : 6342.
  • 8SUNG M K, YEON J Y, PARK S Y, et al. Obesity - induced metabolic stresses in breast and colon cancer [ J ]. Ann N Y Acad Sci, 2011, 1229:61-68.
  • 9WEBER C. Nutrition. Diet change alters microbiota and might affect cancer risk [ J ]. Nat Rev Gastroenterol Hepatol, 2015, 12 (6) : 314.
  • 10ARTHUR J C, JOBIN C. The complex interplay between inflammation, the mierobiota and eolorectal cancer[J]. Gut blierobes, 2013, 4 (3): 253-258.

引证文献3

二级引证文献20

中华消化杂志
2013年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部